The Mark Foundation for Cancer Research
Overview
The Mark Foundation for Cancer Research is a non-profit organization that accelerates research to transform the prevention, diagnosis, and treatment of cancer through grants and early-stage venture investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vicinitas Therapeutics | Jul 2022 | Series A | Co-investor |
| TORL BioTherapeutics | Apr 2023 | Series B | - |
| Accent Therapeutics | Jan 2024 | Series C | Co-investor |
| Immunitas Therapeutics | Aug 2021 | Series B | Co-investor |
| Hyku Biosciences | Nov 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Janice Lin
Portfolio Manager, Research Investments
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Mark Foundation for Cancer Research based?
The Mark Foundation for Cancer Research is headquartered in New York City, New York, United States.
When was The Mark Foundation for Cancer Research founded?
The Mark Foundation for Cancer Research was founded in 2017.
How many portfolio companies does The Mark Foundation for Cancer Research have?
The Mark Foundation for Cancer Research has 18 portfolio companies in Caplight's dataset.
What are some companies in The Mark Foundation for Cancer Research's portfolio?
Portfolio companies visible on Caplight include Vicinitas Therapeutics, TORL BioTherapeutics, Accent Therapeutics, Immunitas Therapeutics, Hyku Biosciences.
What was The Mark Foundation for Cancer Research's most recent investment shown here?
The Mark Foundation for Cancer Research's most recent investment in this portfolio sample was in Hyku Biosciences in 2024.
What sectors does The Mark Foundation for Cancer Research focus on?
The Mark Foundation for Cancer Research focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does The Mark Foundation for Cancer Research focus on?
The Mark Foundation for Cancer Research typically invests at the Early stage.
What is The Mark Foundation for Cancer Research's AUM?
The Mark Foundation for Cancer Research's assets under management are estimated between $100.0M and $250.0M.